SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-002305
Filing Date
2024-01-08
Accepted
2024-01-08 17:14:43
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm242348d1_s3.htm S-3 211403
2 EXHIBIT 5.1 tm242348d1_ex5-1.htm EX-5.1 11473
3 EXHIBIT 23.1 tm242348d1_ex23-1.htm EX-23.1 2354
4 EX-FILING FEES tm242348d1_ex-filingfees.htm EX-FILING FEES 12595
5 GRAPHIC tm242348-1_s3img001.jpg GRAPHIC 16200
6 GRAPHIC image_001.jpg GRAPHIC 3150
  Complete submission text file 0001104659-24-002305.txt   265991
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276429 | Film No.: 24521029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)